Item 1.01 Entry into a Material Definitive Agreement

On May 19, 2021, CannaPharmaRX (the "Company") entered into a Consulting and Broker Agreement (the "Agreement") with K&K Consultants, Ltd. ("K&K"). The material terms of the Agreement provide that K&K agrees to identify prospective business clients and act as an intermediary broker for the Company's products. In return, the Company will pay K&K a five percent (5%) fee of net value of product purchased or sold by the Company as a result of K&K's introduction. This Agreement is to remain effective for a one (1) year period. The Agreement shall be renewed automatically on a year-to-year basis. This agreement can be terminated within thirty (30) days notice.

The Agreement is incorporated herein as if set forth as Exhibit 10.X.

Item 7.01 Regulation FD Disclosure

Attached is a copy of a press release being issued by the Company relating to the Purchase and Sale Agreement, a copy of which is attached as Exhibit 99.6 and is hereby incorporated.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.



Number Exhibit


10.5   Consulting and Broker Agreement


99.6   Press Release announcing Consulting and Broker Agreement








  2

© Edgar Online, source Glimpses